Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV Type 1-Infected Subjects

Treatment of HIV infection with conventional antiretroviral therapy (ART) is a lifelong challenge with significant long-term risks of adverse events and treatment failure-induced HIV resistance being major concerns. One potential alternative to standard treatment is the use of viral decay accelerato...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hicks, Charles, Clay, Patrick, Redfield, Robert, Lalezari, Jay, Liporace, Ralph, Schneider, Stefan, Sension, Michael, McRae, MaryPeace, Laurent, Jean-Pierre
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2013
Témata:
Clinical Trials/Clinical Studies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552433/
https://ncbi.nlm.nih.gov/pubmed/22738014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2012.0093
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky